ICU UK MEDICAL LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +16.4%

  £10,572,500 → £12,308,577

• Cash

  +120%

  £366,280 → £805,993

• Net assets

  +14.5%

  £2,596,494 → £2,973,199

• Employees

  -18.8%

  16 → 13

• Operating profit

  +7.7%

  £342,792 → £369,257

• Profit before tax

  +7.7%

  £342,792 → £369,257

• Wages

  -28.2%

  £1,595,710 → £1,146,473

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

Forvis Mazars LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In addition, at the time of approving the financial statements, the directors have reasonable assurance that the immediate parent undertaking, ICU Medical BV, will provide adequate financial support if needed to allow the company to continue in operational existence for the foreseeable future. Therefore the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”

Significant events

• “Subsequently to the year end, the United States of America announced the implementation of increased tariffs on a range of goods imported from various countries. Some of those impacted countries have implemented retaliatory measures, further influencing global economic conditions. At the date of signing of these financial statements, the Company is in the process of quantifying the financial impact of these increased tariffs on its operations. Whilst the exact financial implications are still being determined, the Company does not anticipate that these measures will have a material effect on its financial performance.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

3

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.